e-learning
resources
Munich 2014
Sunday, 07.09.2014
Pulmonary fibrosis: receptors, signalling pathways and mesenchymal cells
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Functional and molecular disparities between mesenchymal stem cells from various pulmonary disorders
C. Rio, A. Jahn, P. Marti, A. Iglesias, L. Fueyo, O. Gigirey, J. A. Torrecilla, A. Carvajal, C. Balaguer, A. Noguera, A. Peralta, L. Ortiz, E. Sala-Llinas (Palma de Mallorca, Spain; Pittsburgh, United States Of America)
Source:
International Congress 2014 – Pulmonary fibrosis: receptors, signalling pathways and mesenchymal cells
Session:
Pulmonary fibrosis: receptors, signalling pathways and mesenchymal cells
Session type:
Oral Presentation
Number:
1420
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Rio, A. Jahn, P. Marti, A. Iglesias, L. Fueyo, O. Gigirey, J. A. Torrecilla, A. Carvajal, C. Balaguer, A. Noguera, A. Peralta, L. Ortiz, E. Sala-Llinas (Palma de Mallorca, Spain; Pittsburgh, United States Of America). Functional and molecular disparities between mesenchymal stem cells from various pulmonary disorders. Eur Respir J 2014; 44: Suppl. 58, 1420
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Abnormal respiratory epithelial repair in chronic obstructive pulmonary disease
Source: International Congress 2014 – Mechanisms of COPD and inhalation injury
Year: 2014
Injury and repair responses of parenchymal fibroblasts in advanced chronic obstructive pulmonary disease
Source: International Congress 2014 – Mechanisms of COPD: proteases and a whole lot more
Year: 2014
Matriptase triggers pleiotropic functional responses in normal human lung fibroblasts (NHLF): Potential relevance in pathophysiology
Source: International Congress 2014 – Lung cell biology in injury and repair
Year: 2014
The role of Frizzled8 in idiopathic pulmonary fibrosis
Source: International Congress 2014 – New and old players in fibrotic lung disease
Year: 2014
Proteasome function in pulmonary fibrosis
Source: International Congress 2014 – Pulmonary fibrosis: receptors, signalling pathways and mesenchymal cells
Year: 2014
Effect of statins on endothelial dysfunction in patients with chronic obstructive pulmonary disease and metabolic syndrome
Source: International Congress 2014 – Mechanisms of COPD and inhalation injury
Year: 2014
Identification of novel proteins involved in beta-catenin dependent alveolar epithelial trans-differentiation
Source: International Congress 2014 – New and old players in fibrotic lung disease
Year: 2014
Remodeling of bronchial and pulmonary muscular arteries in mild/moderate COPD
Source: International Congress 2014 – Mechanisms of COPD: proteases and a whole lot more
Year: 2014
LATE-BREAKING ABSTRACT: Age-related PINK1 deficiency promotes mitochondria dysfuntion, epithelial injury and fibrosis in the lung
Source: International Congress 2014 – Lung cell biology in injury and repair
Year: 2014
Impact of Wnt ligand secretion on cellular phenotypes in pulmonary fibrosis
Source: International Congress 2014 – New and old players in fibrotic lung disease
Year: 2014
Regulation of WISP1 by profibrotic cytokines in pulmonary fibrosis
Source: International Congress 2014 – Pulmonary fibrosis: receptors, signalling pathways and mesenchymal cells
Year: 2014
Effects of extracellular vesicles from mesenchymal stromal cells in experimental silicosis
Source: International Congress 2014 – Pulmonary fibrosis: receptors, signalling pathways and mesenchymal cells
Year: 2014
Altered protein homeostasis in pulmonary fibrosis indicates a role for proteasomal activator 200
Source: International Congress 2014 – New and old players in fibrotic lung disease
Year: 2014
Resveratrol regulates ECM remodeling in lung fibrosis
Source: International Congress 2014 – New and old players in fibrotic lung disease
Year: 2014
Abnormal proliferation and differentiation of c-kit+ lung stem cells in pulmonary fibrosis
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015
LATE-BREAKING ABSTRACT: A novel and short-term mouse model of chronic obstructive pulmonary disease
Source: International Congress 2014 – Mechanisms of COPD and inhalation injury
Year: 2014
MiR-214-3p, a new fibromiR involved in the pathogenesis of idiopathic pulmonary fibrosis
Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis
Year: 2014
Induced pluripotent stem cells conditioned media (iPS-cm) modulates macrophage phenotype in the fibrotic lung
Source: International Congress 2014 – Lung cell biology in injury and repair
Year: 2014
Fibroblast-derived non-canonical WNT ligands contribute to attenuated alveolar epithelial repair in COPD
Source: International Congress 2014 – Mechanisms of COPD: proteases and a whole lot more
Year: 2014
Epithelial mesenchymal transition in fibroblastic foci of different fibrosing lung diseases: Repair or remodeling?
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: pathogenesis
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept